杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/20 | 1,947 | 1,964 | 1,937 | 1,962 | +15 | +0.8% | 91,000 |
2021/01/19 | 1,976 | 1,977 | 1,947 | 1,947 | -9 | -0.5% | 118,100 |
2021/01/18 | 1,966 | 1,973 | 1,952 | 1,956 | -8 | -0.4% | 70,100 |
2021/01/15 | 1,966 | 1,979 | 1,959 | 1,964 | -2 | -0.1% | 85,900 |
2021/01/14 | 1,960 | 1,976 | 1,956 | 1,966 | +3 | +0.2% | 100,800 |
2021/01/13 | 1,965 | 1,971 | 1,952 | 1,963 | -20 | -1% | 103,300 |
2021/01/12 | 1,974 | 1,989 | 1,968 | 1,983 | +16 | +0.8% | 127,200 |
2021/01/08 | 1,948 | 1,978 | 1,941 | 1,967 | +19 | +1% | 118,100 |
2021/01/07 | 1,960 | 1,964 | 1,945 | 1,948 | +18 | +0.9% | 102,000 |
2021/01/06 | 1,931 | 1,948 | 1,921 | 1,930 | -8 | -0.4% | 78,800 |
2021/01/05 | 1,923 | 1,949 | 1,910 | 1,938 | +15 | +0.8% | 101,400 |
2021/01/04 | 1,946 | 1,946 | 1,903 | 1,923 | -18 | -0.9% | 100,300 |
2020/12/30 | 1,962 | 1,964 | 1,941 | 1,941 | -22 | -1.1% | 90,100 |
2020/12/29 | 1,947 | 1,963 | 1,938 | 1,963 | +29 | +1.5% | 167,500 |
2020/12/28 | 1,936 | 1,958 | 1,925 | 1,934 | -7 | -0.4% | 186,500 |
2020/12/25 | 1,934 | 1,943 | 1,923 | 1,941 | +21 | +1.1% | 122,100 |
2020/12/24 | 1,931 | 1,934 | 1,912 | 1,920 | +10 | +0.5% | 142,800 |
2020/12/23 | 1,906 | 1,920 | 1,901 | 1,910 | +14 | +0.7% | 91,400 |
2020/12/22 | 1,896 | 1,906 | 1,880 | 1,896 | -7 | -0.4% | 162,100 |
2020/12/21 | 1,901 | 1,911 | 1,890 | 1,903 | -12 | -0.6% | 153,600 |
2020/12/18 | 1,921 | 1,925 | 1,902 | 1,915 | -3 | -0.2% | 179,000 |
2020/12/17 | 1,922 | 1,935 | 1,915 | 1,918 | -3 | -0.2% | 120,800 |
2020/12/16 | 1,947 | 1,952 | 1,917 | 1,921 | -11 | -0.6% | 140,400 |
2020/12/15 | 1,951 | 1,976 | 1,929 | 1,932 | -28 | -1.4% | 187,700 |
2020/12/14 | 1,951 | 1,990 | 1,945 | 1,960 | +21 | +1.1% | 224,500 |
2020/12/11 | 1,928 | 1,939 | 1,915 | 1,939 | +12 | +0.6% | 190,500 |
2020/12/10 | 1,897 | 1,932 | 1,895 | 1,927 | +30 | +1.6% | 297,600 |
2020/12/09 | 1,914 | 1,914 | 1,883 | 1,897 | -3 | -0.2% | 266,200 |
2020/12/08 | 1,863 | 1,904 | 1,860 | 1,900 | +27 | +1.4% | 209,300 |
2020/12/07 | 1,893 | 1,897 | 1,870 | 1,873 | -14 | -0.7% | 152,300 |
2020/12/04 | 1,891 | 1,902 | 1,877 | 1,887 | -12 | -0.6% | 139,400 |
2020/12/03 | 1,882 | 1,901 | 1,873 | 1,899 | +24 | +1.3% | 239,000 |
2020/12/02 | 1,891 | 1,892 | 1,870 | 1,875 | -16 | -0.8% | 184,500 |
2020/12/01 | 1,880 | 1,899 | 1,872 | 1,891 | +14 | +0.7% | 169,300 |
2020/11/30 | 1,928 | 1,935 | 1,875 | 1,877 | -22 | -1.2% | 284,000 |
2020/11/27 | 1,877 | 1,903 | 1,875 | 1,899 | +28 | +1.5% | 287,400 |
2020/11/26 | 1,862 | 1,874 | 1,848 | 1,871 | +8 | +0.4% | 143,600 |
2020/11/25 | 1,877 | 1,879 | 1,857 | 1,863 | +7 | +0.4% | 229,200 |
2020/11/24 | 1,885 | 1,886 | 1,856 | 1,856 | -12 | -0.6% | 155,700 |
2020/11/20 | 1,848 | 1,868 | 1,846 | 1,868 | +10 | +0.5% | 110,000 |
2020/11/19 | 1,852 | 1,860 | 1,843 | 1,858 | -6 | -0.3% | 173,700 |
2020/11/18 | 1,861 | 1,867 | 1,852 | 1,864 | -16 | -0.9% | 164,800 |
2020/11/17 | 1,885 | 1,887 | 1,859 | 1,880 | -5 | -0.3% | 182,700 |
2020/11/16 | 1,900 | 1,902 | 1,885 | 1,885 | -11 | -0.6% | 140,900 |
2020/11/13 | 1,910 | 1,912 | 1,889 | 1,896 | -24 | -1.3% | 118,300 |
2020/11/12 | 1,920 | 1,921 | 1,905 | 1,920 | +3 | +0.2% | 123,700 |
2020/11/11 | 1,945 | 1,945 | 1,906 | 1,917 | -5 | -0.3% | 168,200 |
2020/11/10 | 1,950 | 1,950 | 1,903 | 1,922 | -3 | -0.2% | 191,500 |
2020/11/09 | 1,955 | 1,955 | 1,910 | 1,925 | -36 | -1.8% | 224,300 |
2020/11/06 | 1,981 | 1,981 | 1,908 | 1,961 | -24 | -1.2% | 252,400 |
1051~
1100
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 146,400円 | +8.8% | +99.9% | 3.55% | 9.35倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 231,600円 | +21.7% | +999.9% | 0.00% | 9.64倍 | 3.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 305,000円 | +3.0% | +27.5% | 2.62% | 19.31倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 220,600円 | +0.4% | -8.4% | 2.40% | 28.32倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,800円 | +20.3% | - | 0.00% | 154.85倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム